Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Current Pharmaceutical Biotechnology|January 18, 2011
Mucopolysaccharidosis type III (Sanfilippo Syndrome): emerging treatment strategiesJ de Ruijter, M J Valstar, F A WijburgJournal of Inherited Metabolic Disease|April 9, 2008
Sanfilippo syndrome: a mini-reviewM J Valstar, G J G Ruijter, O P van Diggelen, et al.Journal of Intellectual Disability Research : JIDR|August 25, 2022
Light up: an intervention study of the effect of environmental dynamic lighting on sleep-wake rhythm, mood and behaviour in older adults with intellectual disabilitiesM N Böhmer, A Oppewal, M J Valstar, et al.Journal of Intellectual Disability Research : JIDR|February 17, 2021
Shedding light on light exposure in elderly with intellectual disabilitiesM N Böhmer, M J Valstar, M P J Aarts, et al.Journal of Inherited Metabolic Disease|February 25, 2016
Residual N-acetyl-α-glucosaminidase activity in fibroblasts correlates with disease severity in patients with mucopolysaccharidosis type IIIBO L M Meijer, L Welling, M J Valstar, et al.Molecular Genetics and Metabolism|November 21, 2007
Clinical and genetic spectrum of Sanfilippo type C (MPS IIIC) disease in The NetherlandsG J G Ruijter, M J Valstar, J M van de Kamp, et al.Molecular Genetics & Genomic Medicine|February 12, 2022
A multidisciplinary approach and consensus statement to establish standards of care for Angelman syndromeJessica Duis, Mark Nespeca, Jane Summers, et al.Pageof 1